Trinity Biotech plc
TRIB
$0.6792
-$0.0588-7.97%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 15.84M | 13.43M | 14.68M | 13.90M | 15.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.84M | 13.43M | 14.68M | 13.90M | 15.70M |
| Cost of Revenue | 10.11M | 8.86M | 10.40M | 8.87M | 15.38M |
| Gross Profit | 5.73M | 4.57M | 4.28M | 5.03M | 329.00K |
| SG&A Expenses | 6.42M | 6.94M | 7.68M | 7.91M | 5.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -13.00K | -- | -70.00K | -71.00K | -1.00K |
| Total Operating Expenses | 17.51M | 16.92M | 19.18M | 17.94M | 21.55M |
| Operating Income | -1.67M | -3.49M | -4.50M | -4.04M | -5.84M |
| Income Before Tax | -6.89M | -5.51M | -6.50M | -18.61M | -9.99M |
| Income Tax Expenses | -131.00K | -3.00K | 222.00K | -267.00K | 2.00K |
| Earnings from Continuing Operations | -6.76M | -5.50M | -6.72M | -18.35M | -9.99M |
| Earnings from Discontinued Operations | -- | -- | -1.00K | 12.36M | 1.04M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.76M | -5.50M | -6.72M | -5.99M | -8.95M |
| EBIT | -1.67M | -3.49M | -4.50M | -4.04M | -5.84M |
| EBITDA | -1.51M | -3.03M | -4.27M | -3.55M | -5.10M |
| EPS Basic | -14.28 | -14.36 | -17.54 | -15.64 | -23.47 |
| Normalized Basic EPS | -0.30 | -0.43 | -- | -0.56 | -- |
| EPS Diluted | -14.28 | -14.40 | -17.54 | -15.64 | -23.60 |
| Normalized Diluted EPS | -0.30 | -0.43 | -- | -0.56 | -- |
| Average Basic Shares Outstanding | 9.47M | 7.67M | 7.67M | 7.66M | 7.62M |
| Average Diluted Shares Outstanding | 473.20K | 383.20K | 383.20K | 382.80K | 381.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
